• John G O'Meara, Sharon L R Kardia, Jeffrey J Armon, C Andrew Brown, Eric Boerwinkle, and Stephen T Turner.
• Department of Pharmacy Services, Mayo Clinic and Foundation, Rochester, Minn, USA.
• Arch Intern Med. 2004 Jun 28; 164 (12): 131313181313-8.

BackgroundTwo ethnically different, community-based samples of hypertensive adults were evaluated to determine the prevalence of dyslipidemia and how often dyslipidemia is drug-treated and controlled by such treatment.MethodsWe studied 1286 non-Hispanic black hypertensive subjects from Jackson and 1070 non-Hispanic white hypertensive subjects from Rochester who participated in the Genetic Epidemiology Network of Arteriopathy study. Subjects were categorized according to presence of coronary heart disease and risk factors for coronary heart disease.ResultsPrevalence of dyslipidemia was significantly greater among whites than blacks (women, 64.7% vs 49.5%; and men, 78.4% vs 56.7%; P<.001 for both) and among men than women (PConclusionsDyslipidemia is highly prevalent in hypertensive adults. Fewer than one third of these adults are drug-treated, and fewer than half of those treated achieve recommended goals. Our findings suggest that an alarming 9 of 10 dyslipidemic hypertensive adults have untreated or undertreated dyslipidemia.

39 keywords...

hide…